APPEAL: a toolkit for attracting people who inject drugs with hepatitis C to healthcare systems

被引:0
|
作者
Baptista-Leite, Ricardo [1 ,2 ]
Lopes, Henrique [1 ]
Franco, Diogo [1 ]
Clemens, Timo [2 ]
Brand, Helmut [2 ]
机构
[1] Univ Nova Lisboa, NOVA Ctr Global Hlth, NOVA IMS, Lisbon, Portugal
[2] Maastricht Univ, CAPHRI, Dept Int Hlth, Fac Hlth Med & Life Sci, Maastricht, Netherlands
来源
JOURNAL OF PUBLIC HEALTH-HEIDELBERG | 2024年
基金
英国科研创新办公室;
关键词
Public health; People who inject drugs (PWID); Hepatitis C; Vulnerable groups; Care cascade; Service quality improvement; DISEASE; VIRUS; RISK; HIV; HCV;
D O I
10.1007/s10389-024-02276-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim The "APPEAL" toolkit was developed to address the challenges in diagnosing people who inject drugs (PWID) with hepatitis C (HCV) and engaging them with healthcare systems. It introduces an ecosystemic approach based on health and well-being literacy across awareness, prevention and diagnosis dimensions of the hepatitis C's care cascade (CC) for PWID.Subject and methods The framework incorporated a scoping review and thematic analysis of 54 studies, alongside contributions from 57 hepatitis C key opinion leaders across seven countries. The toolkit is structured around five main axes: problems, solutions, outputs, outcomes and feedback process, employing a holistic perspective that considers economic, legal and social contexts. Eighteen policy prescriptions (PP) are proposed and supported by selective references to ensure relevance and applicability.Results The APPEAL toolkit facilitates a strategic workflow for policymakers, health authorities and patient advocacy organizations, guiding them through action flowcharts to evaluate and enhance their interventions within the hepatitis C's CC for PWID. Notably, its implementation demonstrated potential in identifying and attracting PWID to hepatitis C treatment pathways, contributing to increased diagnostics, education on risk behaviours and raising overall disease awareness. The toolkit's intelligent cycle system supports accountability, enabling continuous data-driven improvement and innovation in addressing hepatitis C.Conclusion The APPEAL toolkit was developed to attract PWID living with HCV to healthcare systems in a proactive manner. By managing information and fostering education on HCV, it aims to amplify awareness, prevention and diagnosis. The toolkit's design and functionality underscore the importance of continuous quality improvement and the potential for its use in internal or external quality audits of healthcare services related to hepatitis C.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Agent, Host, and Environment: Hepatitis C Virus in People Who Inject Drugs
    Hagan, Holly
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (12) : 1819 - 1821
  • [42] Reasons for Not Seeking Hepatitis C Treatment among People Who Inject Drugs
    Morris, Leith
    Selvey, Linda
    Williams, Owain
    Gilks, Charles
    Smirnov, Andrew
    SUBSTANCE USE & MISUSE, 2020, 56 (02) : 175 - 184
  • [43] Hepatitis C virus treatment in people who inject drugs (PWID) in Bangladesh
    Rahman, Mustafizur
    Janjua, Naveed Zafar
    Shafiq, Tanveer Khan Ibne
    Chowdhury, Ezazul Islam
    Sarker, Md. Safiullah
    Khan, Sharful Islam
    Reza, Masud
    Faruque, Mohammad Omar
    Kabir, Ahmedul
    Anis, Aslam H.
    Azim, Tasnim
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 74 : 69 - 75
  • [44] Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India
    Clipman, Steven J.
    Mehta, Shruti H.
    Rodgers, Mary A.
    Duggal, Priya
    Srikrishnan, Aylur K.
    Saravanan, Shanmugam
    Balakrishnan, Pachamuthu
    Vasudevan, Canjeevaran K.
    Ray, Stuart C.
    Kumar, Muniratnam S.
    Quinn, Thomas C.
    Cloherty, Gavin A.
    Lucas, Gregory M.
    Solomon, Sunil S.
    HEPATOLOGY, 2021, 74 (04) : 1782 - 1794
  • [45] Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
    Falade-Nwulia, Oluwaseun
    Hackman, Jada
    Mehta, Shruti H.
    McCormick, Sean D.
    Kirk, Gregory D.
    Sulkowski, Mark
    Thomas, David
    Latkin, Carl
    Laeyendecker, Oliver
    Ray, Stuart C.
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [46] Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
    Oluwaseun Falade-Nwulia
    Jada Hackman
    Shruti H. Mehta
    Sean D. McCormick
    Gregory D. Kirk
    Mark Sulkowski
    David Thomas
    Carl Latkin
    Oliver Laeyendecker
    Stuart C. Ray
    BMC Infectious Diseases, 20
  • [47] Monitoring hepatitis C elimination among people who inject drugs: A broader approach is required
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2025, 137
  • [48] Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs
    Rosenthal, Elana S.
    Silk, Rachel
    Mathur, Poonam
    Gross, Chloe
    Eyasu, Rahwa
    Nussdorf, Laura
    Hill, Kristi
    Brokus, Christopher
    D'Amore, Aaron
    Sidique, Nadeera
    Bijole, Phyllis
    Jones, Miriam
    Kier, Randy
    McCullough, Dana
    Sternberg, David
    Stafford, Kristen
    Sun, Junfeng
    Masur, Henry
    Kottilil, Shyamasundaran
    Kattakuzhy, Sarah
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (07) : 1715 - 1722
  • [49] Harm reduction workers and the challenge of engaging couples who inject drugs in hepatitis C prevention
    Treloar, Carla
    Rance, Jake
    Bryant, Joanne
    Fraser, Suzanne
    DRUG AND ALCOHOL DEPENDENCE, 2016, 168 : 170 - 175
  • [50] "No, my name's not on the lease at all": an interpretive phenomenological analysis of unstable housing and hepatitis C among people who inject drugs
    McColl, Roisin
    Higgs, Peter
    Harney, Brendan
    DRUGS HABITS AND SOCIAL POLICY, 2024, 25 (01): : 37 - 50